prednisone has been researched along with Signet Ring Cell Carcinoma in 1 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarro, R | 1 |
| Fiche, M | 1 |
| Bisig, B | 1 |
| Ketterer, N | 1 |
| Benhattar, J | 1 |
| Achtari, C | 1 |
| de Leval, L | 1 |
1 other study available for prednisone and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
An unusual uterine tumor with signet ring cell features.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Thera | 2012 |